Jacobs Levy Equity Management’s LeonaBio Inc LONA Stock Holding History

Jacobs Levy Equity Management’s Portfolio LONA Stock Details LONA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-50,682	Closed	-$1.34M	–	958
2024 Q2	$1.34M	Buy	50,682 +934	+2%	+$22K	0.01%	675
2024 Q1	$1.36M	Buy	49,748 +22,728	+84%	+$721K	0.01%	659
2023 Q4	$657K	Sell	27,020 -2,946	-10%	-$52.3K	﹤0.01%	787
2023 Q3	$605K	Buy	29,966 +9,891	+49%	+$253K	﹤0.01%	764
2023 Q2	$592K	Sell	20,075 -2,033	-9%	-$57.9K	﹤0.01%	790
2023 Q1	$553K	Sell	22,108 -3,162	-13%	-$102K	﹤0.01%	791
2022 Q4	$801K	Buy	25,270 +76	+0.3%	+$2.4K	0.01%	712
2022 Q3	$748K	Buy	+25,194	New	+$869K	0.01%	768

Other funds holding LONA

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Jacobs Levy Equity Management's LONA Position: Q3 2024 in Review

Jacobs Levy Equity Management sold out of LeonaBio Inc (LONA) in Q3 2024, closing a stake of 50,682 shares — an estimated $1.34M sold.

Jacobs Levy Equity Management first reported a position in LONA in Q3 2022 and held it in 8 quarters. The position peaked at $1.36M in Q1 2024. 58 funds tracked by Wall St. Rank hold LONA as of Q3 2024.

Jacobs Levy Equity Management reported no remaining LeonaBio Inc position as of Q3 2024 after selling out during the quarter.
Jacobs Levy Equity Management sold 50,682 LeonaBio Inc shares in Q3 2024, an estimated $1.34M.
Jacobs Levy Equity Management first reported a position in LeonaBio Inc in Q3 2022 and held it in 8 quarters.
Jacobs Levy Equity Management's LeonaBio Inc position peaked at $1.36M in Q1 2024.
58 funds tracked by Wall St. Rank held LeonaBio Inc as of Q3 2024.

Based on Jacobs Levy Equity Management's 13F filing for Q3 2024, filed 14 Nov 2024.